Journal der Deutschen Dermatologischen Gesellschaft

Papers
(The TQCC of Journal der Deutschen Dermatologischen Gesellschaft is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
976369978
Schwere atopische Dermatitis im frühen Kindesalter: Besonderheiten, Herausforderungen und neue Perspektiven in der Versorgung859190323
Severe atopic dermatitis in early infancy: characteristics, challenges and new perspectives in clinical practice842280240
Kongresskalender 2024842021426
S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma – short version, part 1: diagnosis, interventions for actinic keratoses, care structures and quality‐of‐care indicators39
S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma (cSCC) – short version, part 2: epidemiology, surgical and systemic treatment of cSCC, follow‐up, prevention and occupational d38
COVID‐19 and immunological regulations – from basic and translational aspects to clinical implications29
JAK‐inhibitors in dermatology – small molecules, big impact? Overview of the mechanism of action, previous study results and potential adverse effects27
Update “Systemic treatment of atopic dermatitis” of the S2k‐guideline on atopic dermatitis26
Drug‐induced photosensitivity: culprit drugs, potential mechanisms and clinical consequences26
COVID‐19 and implications for dermatological and allergological diseases25
Lichen planus – a clinical guide25
German S3‐Guideline on the treatment of Psoriasis vulgaris, adapted from EuroGuiDerm – Part 1: Treatment goals and treatment recommendations22
Modern therapies in atopic dermatitis: biologics and small molecule drugs20
Stigmatization caused by hair loss – a systematic literature review20
Overdiagnosis of melanoma – causes, consequences and solutions20
German S3‐Guideline on the treatment of Psoriasis vulgaris, adapted from EuroGuiDerm – Part 2: Treatment monitoring and specific clinical or comorbid situations19
Inpatient care for skin diseases in Germany: multi‐source analysis on the current and future health care needs19
Non‐alcoholic fatty liver disease and psoriasis – is there a shared proinflammatory network?18
Teledermatology in the times of COVID‐19 – a systematic review17
S2k guideline: Rosacea17
Known and new facts on basal cell carcinoma17
COVID‐19 und Immunregulation – von grundlegenden und translationalen Aspekten zu klinischen Implikationen16
Deutsche S3‐Leitlinie zur Therapie der Psoriasis vulgaris, adaptiert von EuroGuiDerm – Teil 1: Therapieziele und Therapieempfehlungen15
Erythema multiforme, Stevens‐Johnson syndrome/toxic epidermal necrolysis – diagnosis and treatment15
The role of the skin microbiome in atopic dermatitis – correlations and consequences14
Dyskeratosis congenita: a literature review14
S3 – Leitlinie zur Diagnostik, Therapie und Nachsorge des Melanoms14
Cytokines of the IL‐17 family in psoriasis13
Ultrasonography in dermatologic surgery: revealing the unseen for improved surgical planning13
Borrelia burgdorferi in primary cutaneous lymphomas: a systematic review and meta‐analysis13
Rechallenge with checkpoint inhibitors in metastatic melanoma13
Application errors associated with topical treatment of scabies: an observational study13
Current developments and perspectives in psoriasis13
The impact of clinical nutrition on inflammatory skin diseases13
Manifestations, clinical course and prognostic markers in cutaneous polyarteritis nodosa12
Side effect management during immune checkpoint blockade using CTLA‐4 and PD‐1 antibodies for metastatic melanoma – an update12
Sex hormones and acne: State of the art12
Alleviation of erosive oral and esophageal lichen planus by the JAK1 inhibitor upadacitinib12
S2k‐Leitlinie zur Therapie des Pemphigus vulgaris/foliaceus und des bullösen Pemphigoids: 2019 Update12
Management of chlormethine gel treatment in mycosis fungoides patients in two German skin lymphoma centers11
Subcutaneous white adipose tissue: The deepest layer of the cutaneous immune barrier11
Comparative efficacy and safety of biologics in moderate to severe plaque psoriasis: a multiple‐treatments meta‐analysis11
The importance of total‐body photography and sequential digital dermatoscopy for monitoring patients at increased melanoma risk11
Tattoos – more than just colored skin? Searching for tattoo allergens11
S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid: 2019 update11
Skin and Psychosomatics – Psychodermatology today11
Dermatophyte infections in children compared to adults in Germany: a retrospective multicenter study in Germany11
Postoperative complications in dermatological patients undergoing microscopically controlled surgery in inpatient setting (next‐day surgery): A single‐center epidemiological study11
Pilot study on the influence of cold atmospheric plasma on bacterial contamination and healing tendency of chronic wounds11
Characterization of the effects on pruritus by novel treatments for atopic dermatitis11
Primary cutaneous T‐cell lymphomas in childhood and adolescence11
Dupilumab for treatment‐refractory prurigo nodularis10
S2k Leitlinie: Diagnostik und Therapie des chronischen Pruritus10
Deutsche S3‐Leitlinie zur Therapie der Psoriasis vulgaris, adaptiert von EuroGuiDerm – Teil 2: Therapiemonitoring, besondere klinische Situationen und Komorbidität10
Chronic kidney disease in psoriasis: a cohort study10
German S1 guideline: Contact dermatitis10
Fixed drug eruptions – the common and novel culprits since 200010
Management of giant congenital nevi in infants by excision under local anesthesia10
Topical sodium thiosulfate: a reliable treatment for digital calcinosis cutis – a case series with six patients9
S2k‐Leitlinie – Kutane Lymphome (ICD10 C82–C86): Update 20219
Benefits, safety and side effects of tumescent local anesthesia in dermatologic surgery in infants9
S2k Guideline for the diagnosis and treatment of mucous membrane pemphigoid9
Comparative appraisal with meta‐analysis of erbium vs. CO2 lasers for atrophic acne scars9
Comorbid diseases among bullous pemphigoid patients in Germany: new insights from a case‐control study9
Immunizations in immunocompromised patients: a guide for dermatologists9
Sensitization rates to common inhaled allergens in Germany – increase and change patterns over the last 20 years9
Characteristics of dermatomyositis patients with and without associated malignancy9
Despite large choice of effective therapies: Individuals with psoriasis still seem undertreated9
Could cellular and signaling abnormalities converge to provoke atopic dermatitis?9
Screening for depression in psoriasis patients during a dermatological consultation: A first step towards treatment9
Diagnosis and therapy of Mycobacterium marinum: a single‐center 21‐year retrospective analysis9
NTRK gene fusions in melanoma: detection, prevalence and potential therapeutic implications9
Autoimmune bullous dermatoses8
Association between vitiligo and relevant components of metabolic syndrome: a systematic review and meta‐analysis8
Comparison of patient pathways in the early detection of skin cancer – a claims data analysis8
Low‐dose total skin electron beam therapy plus oral bexarotene maintenance therapy for cutaneous T‐cell lymphoma8
Documentation of psoriasis in routine care – expert consensus on a German data set8
Association between bullous pemphigoid and psychiatric disorders: A systematic review and meta‐analysis8
S2k guideline: Diagnosis and treatment of chronic pruritus8
German evidence and consensus‐based (S3) guideline: Vaccination recommendations for the prevention of HPV‐associated lesions8
Immunological features and factors associated with mucocutaneous bullous pemphigoid – a retrospective cohort study8
Psoriasis or eczema? One‐year results from the DGUV research project FB323 with application of the Molecular Classifier in occupational dermatoses8
Psoriasis 2.0: Facebook as a source of disease‐related information for patients with psoriasis8
Adjuvant treatment with secukinumab induced long term remission in a patient with severe bullous pemphigoid8
Continuing medical and student education in dermatology during the coronavirus pandemic – a major challenge8
S1 Guideline: Diagnosis and therapy of vitiligo8
Biologics for pediatric moderate‐to‐severe plaque psoriasis: a systematic review and network meta‐analysis7
Dupilumab in eosinophilic cellulitis (Wells’ syndrome) – case report of a potential new treatment option7
Systemic immunosuppression in times of COVID‐19: Do we need to rethink our standards?7
Atopic skin diathesis rather than atopic dermatitis is associated with specific contact allergies7
Patient preferences for treatment of advanced melanoma: impact of comorbidities7
Ichthyosen im klinischen Alltag: Umgang mit einer seltenen Erkrankungsgruppe7
Skin manifestations reported in association with COVID‐19 infection7
TYK2 inhibition and its potential in the treatment of chronic inflammatory immune diseases7
Acute generalized pustular psoriasis successfully treated with the IL‐23p19 antibody risankizumab7
Two questions may be enough – screening for depression in patients with psoriasis: a multicenter study7
Cutaneous Angiosarcomas: Molecular Pathogenesis Guides Novel Therapeutic Approaches7
Comedonal Darier’s disease: six additional cases and a review of this entity7
German S1 guidelines for the diagnosis and treatment of perianal dermatitis (anal eczema)7
Epidemiology of skin diseases in Germany: systematic review of the current state of research – part 1: cutaneous tumor diseases7
Update on dermatomyositis in adults7
Sexually transmitted coinfections in patients with anogenital warts – a retrospective analysis of 196 patients7
Figurate erythemas – update and diagnostic approach7
Molecular diagnostics in dermatology: An online survey to study usage, obstacles and requirements in Germany7
Topical calcineurin inhibitors and risk of lymphoma: a systematic review and meta‐analysis7
S2k guideline: Diagnosis and management of cutaneous lupus erythematosus – Part 1: Classification, diagnosis, prevention, activity scores7
Nailfold videocapillaroscopy identifies microvascular pathologies in psoriasis vulgaris: Results of a prospective controlled study7
Häufige Nagelerkrankungen: Diagnostik und Therapie7
S2k guidelines for the therapy of pathological scars (hypertrophic scars and keloids) – Update 20207
Cardiovascular comorbidity in psoriasis – psoriatic inflammation is more than just skin deep7
S1‐Leitlinie Diagnostik und Therapie der Livedovaskulopathie6
Risk factors for early‐onset basal cell carcinomas and the trend towards their female predominance6
Clinical features and treatments of transient acantholytic dermatosis (Grover’s disease): a systematic review6
Importance of diagnostics and risk of secondary malignancies in primary cutaneous lymphomas6
The optimal use of chlormethine gel for mycosis fungoides: An expert consensus from Germany, Austria and Switzerland (DACH region)6
Bekanntes und Neues zum Basalzellkarzinom6
Paraneoplastic pemphigus associated with Castleman's disease and thyroid carcinoma with anti‐BP180, BP230 and antidesmocollin autoantibodies6
Collective human intelligence outperforms artificial intelligence in a skin lesion classification task6
Diagnostic value of laboratory parameters for the discrimination between erysipelas and limited cellulitis6
Therapy of psoriasis during pregnancy and breast‐feeding6
S1‐guideline atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS)6
The spectrum of melanocytic nevi and their clinical implications6
Status quo und Perspektiven der Hautkliniken in Deutschland: Versorgungsspektren und Personalsituation6
Effectiveness and safety of dupilumab for atopic dermatitis in a liver transplant recipient: a case report6
Moisture‐associated skin damage (MASD): A best practice recommendation from Wund‐D.A.CH.6
German S1 guideline: diagnosis and treatment of livedovasculopathy6
Infectious exanthemas in childhood6
“Indian” strains of Trichophyton mentagrophytes with reduced itraconazole susceptibility in Germany6
Vexas syndrome successfully treated with canakinumab6
S1‐Guideline: Microscopically controlled surgery6
Alopecia areata – Current understanding and management6
Inpatient dermatology: Where are we headed? A nationwide population‐based study of Spain from 2006 to 20166
Epidemiology of skin diseases in Germany: systematic review of the current state of research – part 2: non‐infectious skin diseases6
Epidermal necrolysis in the context of immuno‐oncologic medication as well as kinase inhibitors and biologics6
S2k‐Guideline for Teledermatology6
Real‐world systemic treatment of patients with psoriasis: A retrospective study based on German claims data6
Impact of the COVID‐19 pandemic on the care of patients with malignant melanoma6
Combination of brentuximab‐vedotin with skin‐directed therapies extends the time to the next therapeutic line in patients with cutaneous T‐cell lymphoma6
Die (neue) Berufskrankheit Nr. 5101: „Schwere oder wiederholt rückfällige Hauterkrankungen“5
Risk of complications due to antithrombotic agents in cutaneous surgery: a systematic review and meta‐analysis5
Generalized pustular psoriasis: overview of the status quo and results of a panel discussion5
Driving CAR T cells towards dermatologic oncology5
Phenotypic and genetic spectrum of incontinentia pigmenti – a large case series5
Rat bite fever, a diagnostic challenge: case report and review of 29 cases5
Common diseases of the nail: Diagnosis and therapy5
Disease progression and response to therapy in pemphigus based on a registry5
Dermatoscopic features of pigmented intraepidermal carcinoma on the head and neck5
Haut und Psychosomatik – Psychodermatologie heute5
Therapy understanding and health related quality of life in stage III/IV melanoma patients treated with novel adjuvant therapies5
Modern diabetes devices for continuous blood sugar measuring: Limitations due to contact allergies5
Diagnostic next generation sequencing in neonatal erythroderma5
S2k‐Leitlinie: Lasertherapie der Haut5
Scleromyxedema5
Ocular syphilis – a case series of four patients5
Bullous pemphigoid without detection of autoantibodies in a patient with psoriasis under ustekinumab5
Evaluation of the efficacy of subantimicrobial dose doxycycline in rosacea: a systematic review of clinical trials and meta‐analysis5
Recurrent mucocutaneous infections caused by PVL‐positive Staphylococcus aureus strains: a challenge in clinical practice5
Pregnancy in a patient with metastatic uveal melanoma treated with nivolumab5
Effective treatment with mepolizumab in a patient with refractory Wells syndrome5
Severe side effects of targeted therapies5
Psychological morbidity in pemphigus patients in clinical remission and its relation with clinico‐demographic parameters5
The combination of the Wilson bridge flap with A‐T advancement flap for extensive red lip defects and defects of the skin of the lip5
Strukturen und Leistungsmerkmale der Hautkliniken in Deutschland: Aktuelle Bestandsaufnahme und Langzeitverlauf5
Dermatopathology – Current status and development in German‐speaking dermatology5
Combination therapy of oral propranolol and combined Nd:YAG/pulsed dye laser therapy in infantile hemangiomas: a retrospective analysis of 48 treated hemangiomas in 30 children5
Autoimmune skin disorders and SARS‐CoV‐2 vaccination – a meta‐analysis5
PET/CT in malignant melanoma: a two‐tiered healthcare system? Updated healthcare situation regarding initial staging of malignant melanoma with PET/CT5
Is there an overtreatment of melanoma patients at the end of their life? Results of a multicenter study on 193 melanoma patients5
Mento‐buccal bilobed flap for closure of large defects of the cheek and temple5
S1‐Leitlinie: Mikroskopisch kontrollierte Chirurgie5
S2k‐Leitlinie: Rosazea5
Hydroxychloroquine‐induced acute generalized exanthematous pustulosis: an adverse reaction to keep in mind during COVID‐19 pandemic5
A distinctive bullous skin reaction associated with enfortumab vedotin‐ejfv treatment for metastatic urothelial cancer: A case report5
Linear patterns of the skin and their dermatoses5
Drug eruptions with novel targeted therapies – immune checkpoint and EGFR inhibitors5
Nebenwirkungsmanagement bei Immun‐Checkpoint‐Blockade durch CTLA‐4‐ und PD‐1‐Antikörper beim metastasierten Melanom – ein Update5
Metastatic Crohn’s disease: an underestimated entity5
Surgical lymphology. Therapy option for lymphoedema and lipohyperplasia dolorosa5
Congenital cutaneous neurofibromas in neurofibromatosis type 1: Clinicopathological features in early infancy5
Response of rheumatoid arthritis‐associated pyoderma gangrenous to the JAK1 inhibitor upadacitinib5
Quality assurance in melanoma care: guideline‐based quality indicators for melanoma – implementation, evaluation and update process5
Care structure of patients with mycosis fungoides and Sézary syndrome in Germany – Care research based on SHI claims data5
Perioperative antibiotic prophylaxis in skin surgery – Position paper of the Antibiotic Stewardship working group of the German Society for Dermatologic Surgery (DGDC), Part 1: Procedure‐ and patient‐5
Stationäre Versorgung von Hautkrankheiten in Deutschland: Multi‐Source‐Analyse zum aktuellen und zukünftigen Bedarf4
3D printing and silicone models of primary skin lesions for dermatological education as remote learning tool4
S3‐Leitlinie Urtikaria. Teil 1: Klassifikation und Diagnostik der Urtikaria – deutschsprachige Adaptation der internationalen S3‐Leitlinie4
S3‐Leitlinie „Aktinische Keratose und Plattenepithelkarzinom der Haut“ – Kurzfassung, Teil 1: Diagnostik, Interventionen bei aktinischen Keratosen, Versorgungsstrukturen und Qualitätsindikatoren4
S1‐Leitlinie Onychomykose4
Epidemiology of urticaria in German children4
Cutaneous tuberculosis in a patient with a STAT1 mutation4
Automatic body part identification in real‐world clinical dermatological images using machine learning4
Methotrexate‐induced epidermal necrosis in a child with osteosarcoma4
Corona – und kein Ende?4
Comparison of fractional laser‐assisted drug delivery and intralesional injection of triamcinolone acetonide in nail psoriasis4
Hidradenitis suppurativa‐related expenditure, a call for awareness: systematic review of literature4
Ichthyoses in everyday practice: management of a rare group of diseases4
Behandlung refraktärer Anti‐NXP2‐ und Anti‐TIF1γ‐Dermatomyositis mit Tofacitinib4
Psoriasis is associated with fissured tongue but not geographic tongue: a prospective, cross‐sectional, case‐control study4
Epidermotropism of inflammatory cells differentiates pyoderma gangrenosum from venous leg ulcers4
Recalcitrant Sweet Syndrome successfully treated with adalimumab4
Rosacea and perioral dermatitis: a single‐center retrospective analysis of the clinical presentation of 1032 patients4
Alemtuzumab‐induced Alopecia areata – a case report and systematic literature review of adverse events associated with Alemtuzumab4
Behçet’s‐like disease during secukinumab treatment: new paradoxical reaction?4
COVID‐19 und Auswirkungen auf dermatologische und allergologische Erkrankungen4
Esophageal lichen planus successfully treated with the JAK1/3 inhibitor tofacitinib4
Treatment of pityriasis rubra pilaris with risankizumab in two cases4
Inherited ichthyosis and fungal infection: an update on pathogenesis and treatment strategies4
S3‐Leitlinie Urtikaria. Teil 2: Therapie der Urtikaria – deutschsprachige Adaption der internationalen S3‐Leitlinie4
Cutaneous squamous cell carcinoma: state of the art, perspectives and unmet needs4
Vaccine response against SARS‐CoV‐2 under immunomodulatory systemic therapies in dermatology4
Dermatologische Empfehlungen zur Handhygiene in Schulen während der COVID‐19‐Pandemie4
S3 guideline: Management of anticoagulants and antiplatelet agents in cutaneous surgery4
Post‐operative follow‐up of 150 patients with sentinel lymph node biopsy under tumescence local anesthesia4
Sjögren’s syndrome4
Two‐stage pedicled interpolation flap with wings for reconstruction of combined nasal tip/columella defects4
Successful therapy of acrodermatitis continua of Hallopeau with IL‐23 blockers –two new cases4
Psoriasis vulgaris triggered by treatment with mogamulizumab in a patient with cutaneous T‐cell lymphoma4
Corona pandemic: Teachings for dermatological teaching4
Lupus erythematosus: correlation of clinical and histological findings and proposal for a modified disease classification4
Clinical overlap between CLAPO syndrome and macrocephaly‐capillary malformation syndrome4
Sleep disorders in dermatology – a comprehensive review4
Medical error analysis in dermatology according to the reports of the North Rhine Medical Association from 2004 to 20184
Truncal giant congenital melanocytic nevus involving the breast in a girl reaching puberty: excision by expander technique4
Dark corner artefact and diagnostic performance of a market‐approved neural network for skin cancer classification4
Routine application of ex vivo confocal laser scanning microscopy with digital staining for examination of surgical margins in basal cell carcinomas4
Use of local anesthetics with an epinephrine additive on fingers and penis – dogma and reality4
High prevalence and little awareness in patients with chronic inflammatory skin diseases and genital involvement4
S2k‐Guidelines – Cutaneous lymphomas (ICD10 C82 ‐ C86): Update 20214
Methotrexate for atopic dermatitis in adults: a prospective study from a reference center in Brazil4
Neutrophilic dermatoses – Pathomechanistic concepts and therapeutic developments4
Videodermoscopic clues for scabies diagnosis and assessment of therapeutic efficacy4
Dermatosurgery – from surgical option to integral part of dermatologic therapy4
Calcium electroporation in primary cutaneous marginal zone lymphoma4
S1‐Leitlinie Kontaktekzem4
Meta‐analysis on preventive and therapeutic effects of probiotic supplementation in infant atopic dermatitis3
S2k guideline: Diagnosis and management of cutaneous lupus erythematosus – Part 2: Therapy, risk factors and other special topics3
Allergens in permanent tattoo ink – first results of the Information Network of Departments of Dermatology (IVDK)3
Development and evaluation of an interprofessional teaching concept for modern wound management3
Multiple dermatofibromas, associated clinical and histological characteristics: A systematic review3
Online HIV/STI Risk Test (ORT): A prospective cross‐sectional study among sexually active individuals in Germany3
Diagnostic workup of acroangiodermatitis of Mali (pseudo‐Kaposi sarcoma) demasking metastasized epithelioid angiosarcoma3
Real World treatment patterns of hereditary angioedema with lanadelumab in Germany: A prescription data analysis3
Comorbid diseases associated with pemphigus: a case‐control study3
Folliculotropism in head and neck lentigo maligna and lentigo maligna melanoma3
Sicherheit eines Kompressionsstrumpfes für Patienten mit chronischer venöser Insuffizienz (CVI) und peripherer arterieller Verschlusskrankheit (pAVK)3
Sustained complete remission of extranodal NK/T‐cell lymphoma, nasal type, following pembrolizumab and radiation therapy3
Personalized management for Gorlin‐Goltz Syndrome: Experience of combination therapy and our algorithm for treatment3
The (new) occupational disease no. 5101: “Severe or recurrent skin diseases”3
Atopic dermatitis – Perspectives and unmet medical needs3
0.034662961959839